Cerevel Therapeutics Holdings IncNASDAQ:CERE
- LAST PRICE41.3300
- TODAY'S CHANGE (%)-0.3000 (-0.7206%)
- Bid / Lots41.3300/ 1
- Ask / Lots41.6700/ 18
- Open / Previous Close41.5200 / 41.6300
- Day Range
- 52 Week Range
- Volume731,926
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CERE |
|---|---|---|
| 09:32 ET | 15435 | 41.48 |
| 09:34 ET | 1852 | 41.5 |
| 09:38 ET | 12111 | 41.51 |
| 09:39 ET | 1100 | 41.51 |
| 09:41 ET | 1866 | 41.505 |
| 09:43 ET | 1365 | 41.545 |
| 09:45 ET | 12466 | 41.5 |
| 09:48 ET | 9731 | 41.495 |
| 09:50 ET | 2003 | 41.5 |
| 09:52 ET | 1500 | 41.505 |
| 09:54 ET | 1200 | 41.495 |
| 09:56 ET | 4535 | 41.505 |
| 09:57 ET | 741 | 41.5 |
| 09:59 ET | 400 | 41.51 |
| 10:01 ET | 1941 | 41.51 |
| 10:03 ET | 500 | 41.505 |
| 10:06 ET | 148 | 41.505 |
| 10:08 ET | 3446 | 41.5 |
| 10:10 ET | 698 | 41.51 |
| 10:12 ET | 1252 | 41.515 |
| 10:14 ET | 736 | 41.51 |
| 10:15 ET | 1500 | 41.505 |
| 10:17 ET | 2593 | 41.52 |
| 10:19 ET | 2052 | 41.53 |
| 10:21 ET | 1594 | 41.565 |
| 10:24 ET | 1139 | 41.535 |
| 10:26 ET | 899 | 41.535 |
| 10:28 ET | 700 | 41.54 |
| 10:30 ET | 700 | 41.54 |
| 10:32 ET | 135 | 41.545 |
| 10:33 ET | 100 | 41.545 |
| 10:35 ET | 410 | 41.545 |
| 10:37 ET | 1487 | 41.555 |
| 10:39 ET | 8998 | 41.53 |
| 10:42 ET | 3046 | 41.535 |
| 10:44 ET | 1652 | 41.535 |
| 10:46 ET | 1300 | 41.535 |
| 10:48 ET | 870 | 41.535 |
| 10:50 ET | 1098 | 41.535 |
| 10:51 ET | 1230 | 41.54 |
| 10:53 ET | 697 | 41.54 |
| 10:55 ET | 100 | 41.54 |
| 10:57 ET | 2560 | 41.535 |
| 11:00 ET | 900 | 41.535 |
| 11:02 ET | 300 | 41.53 |
| 11:04 ET | 1370 | 41.52 |
| 11:06 ET | 5799 | 41.49 |
| 11:08 ET | 7196 | 41.51 |
| 11:09 ET | 1000 | 41.52 |
| 11:11 ET | 1266 | 41.52 |
| 11:13 ET | 100 | 41.52 |
| 11:15 ET | 727 | 41.555 |
| 11:18 ET | 1492 | 41.54 |
| 11:20 ET | 1500 | 41.55 |
| 11:22 ET | 6455 | 41.515 |
| 11:24 ET | 2850 | 41.535 |
| 11:26 ET | 1356 | 41.5 |
| 11:27 ET | 1300 | 41.5 |
| 11:29 ET | 500 | 41.5 |
| 11:31 ET | 431 | 41.5 |
| 11:33 ET | 1519 | 41.51 |
| 11:36 ET | 600 | 41.5025 |
| 11:38 ET | 1413 | 41.495 |
| 11:40 ET | 900 | 41.45 |
| 11:42 ET | 700 | 41.425 |
| 11:44 ET | 1268 | 41.43 |
| 11:45 ET | 2753 | 41.455 |
| 11:47 ET | 1079 | 41.48 |
| 11:49 ET | 100 | 41.48 |
| 11:51 ET | 2001 | 41.465 |
| 11:54 ET | 300 | 41.465 |
| 11:56 ET | 1286 | 41.48 |
| 11:58 ET | 1000 | 41.5 |
| 12:00 ET | 542 | 41.5 |
| 12:02 ET | 1700 | 41.505 |
| 12:03 ET | 500 | 41.5 |
| 12:05 ET | 1115 | 41.505 |
| 12:07 ET | 300 | 41.5 |
| 12:09 ET | 1337 | 41.49 |
| 12:12 ET | 1835 | 41.49 |
| 12:14 ET | 100 | 41.5 |
| 12:16 ET | 2600 | 41.51 |
| 12:20 ET | 300 | 41.52 |
| 12:21 ET | 200 | 41.515 |
| 12:23 ET | 839 | 41.495 |
| 12:25 ET | 343 | 41.5 |
| 12:27 ET | 100 | 41.5 |
| 12:30 ET | 600 | 41.5 |
| 12:32 ET | 1205 | 41.495 |
| 12:34 ET | 825 | 41.5 |
| 12:36 ET | 544 | 41.5 |
| 12:38 ET | 2635 | 41.5 |
| 12:39 ET | 200 | 41.5 |
| 12:41 ET | 453 | 41.5 |
| 12:43 ET | 1229 | 41.535 |
| 12:45 ET | 648 | 41.535 |
| 12:48 ET | 200 | 41.525 |
| 12:50 ET | 600 | 41.505 |
| 12:52 ET | 500 | 41.505 |
| 12:54 ET | 420 | 41.51 |
| 12:56 ET | 700 | 41.5025 |
| 12:57 ET | 300 | 41.5025 |
| 12:59 ET | 3686 | 41.5 |
| 01:01 ET | 784 | 41.51 |
| 01:03 ET | 600 | 41.5 |
| 01:06 ET | 2506 | 41.51 |
| 01:08 ET | 100 | 41.5 |
| 01:10 ET | 400 | 41.5 |
| 01:12 ET | 4862 | 41.5 |
| 01:14 ET | 531 | 41.505 |
| 01:15 ET | 700 | 41.51 |
| 01:17 ET | 7448 | 41.5 |
| 01:19 ET | 2500 | 41.495 |
| 01:21 ET | 1321 | 41.495 |
| 01:24 ET | 200 | 41.495 |
| 01:26 ET | 790 | 41.495 |
| 01:28 ET | 100 | 41.495 |
| 01:30 ET | 4749 | 41.51 |
| 01:32 ET | 1678 | 41.53 |
| 01:33 ET | 1388 | 41.505 |
| 01:35 ET | 600 | 41.51 |
| 01:37 ET | 586 | 41.505 |
| 01:39 ET | 2361 | 41.51 |
| 01:42 ET | 763 | 41.52 |
| 01:44 ET | 200 | 41.52 |
| 01:46 ET | 1201 | 41.505 |
| 01:48 ET | 1679 | 41.5025 |
| 01:50 ET | 2600 | 41.51 |
| 01:51 ET | 631 | 41.505 |
| 01:53 ET | 600 | 41.505 |
| 01:55 ET | 600 | 41.51 |
| 01:57 ET | 982 | 41.515 |
| 02:00 ET | 1855 | 41.52 |
| 02:02 ET | 2743 | 41.53 |
| 02:04 ET | 718 | 41.515 |
| 02:06 ET | 400 | 41.525 |
| 02:08 ET | 1000 | 41.525 |
| 02:09 ET | 27061 | 41.525 |
| 02:11 ET | 3230 | 41.5 |
| 02:13 ET | 1814 | 41.5 |
| 02:15 ET | 20074 | 41.5 |
| 02:18 ET | 600 | 41.495 |
| 02:20 ET | 3925 | 41.5 |
| 02:22 ET | 1200 | 41.5 |
| 02:24 ET | 400 | 41.495 |
| 02:26 ET | 7644 | 41.48 |
| 02:27 ET | 3234 | 41.5 |
| 02:29 ET | 400 | 41.5 |
| 02:31 ET | 800 | 41.49 |
| 02:33 ET | 339 | 41.485 |
| 02:36 ET | 200 | 41.485 |
| 02:38 ET | 600 | 41.485 |
| 02:40 ET | 1001 | 41.485 |
| 02:42 ET | 3267 | 41.475 |
| 02:44 ET | 900 | 41.4725 |
| 02:45 ET | 1000 | 41.475 |
| 02:47 ET | 3361 | 41.485 |
| 02:49 ET | 1623 | 41.495 |
| 02:51 ET | 351 | 41.495 |
| 02:54 ET | 600 | 41.495 |
| 02:56 ET | 1629 | 41.48 |
| 02:58 ET | 1606 | 41.465 |
| 03:00 ET | 2524 | 41.465 |
| 03:02 ET | 2829 | 41.435 |
| 03:03 ET | 11866 | 41.385 |
| 03:05 ET | 3580 | 41.37 |
| 03:07 ET | 1276 | 41.38 |
| 03:09 ET | 1817 | 41.4 |
| 03:12 ET | 1000 | 41.4 |
| 03:14 ET | 36436 | 41.445 |
| 03:16 ET | 1200 | 41.435 |
| 03:18 ET | 2125 | 41.41 |
| 03:20 ET | 1830 | 41.4 |
| 03:21 ET | 9724 | 41.42 |
| 03:23 ET | 17047 | 41.395 |
| 03:25 ET | 4100 | 41.34 |
| 03:27 ET | 2421 | 41.35 |
| 03:30 ET | 1000 | 41.355 |
| 03:32 ET | 3541 | 41.355 |
| 03:34 ET | 4550 | 41.315 |
| 03:36 ET | 1200 | 41.32 |
| 03:38 ET | 4026 | 41.345 |
| 03:39 ET | 2750 | 41.36 |
| 03:41 ET | 3808 | 41.355 |
| 03:43 ET | 2236 | 41.34 |
| 03:45 ET | 2134 | 41.34 |
| 03:48 ET | 5605 | 41.34 |
| 03:50 ET | 3880 | 41.34 |
| 03:52 ET | 9757 | 41.345 |
| 03:54 ET | 1800 | 41.345 |
| 03:56 ET | 6192 | 41.34 |
| 03:57 ET | 8905 | 41.335 |
| 03:59 ET | 138144 | 41.33 |
Today
Yesterday
May 23, 2024
Cerevel Therapeutics is Being Investigated After Announcing a $45 Per Share Merger Offer from AbbVie - Contact BFA Law to Discuss How this Impacts You, from 4:04PM ET on Thursday May 23, 2024 by Dow Jones
4:04PM ET on Thursday May 23, 2024 by Dow JonesIs Cerevel's Merger with AbbVie for $45 Per Share Too Low? BFA Law is Investigating, from 11:38AM ET on Thursday May 23, 2024 by Dow Jones
11:38AM ET on Thursday May 23, 2024 by Dow Jones
May 22, 2024
ATTENTION CEREVEL SHAREHOLDERS: BFA Law Announces Investigation Into Whether the $45 Per Share Merger Offer is Too Low, from 3:58PM ET on Wednesday May 22, 2024 by Dow Jones
3:58PM ET on Wednesday May 22, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cerevel Therapeutics Holdings Inc | 7.5B | -15.2x | --- |
Vaxcyte Inc | 7.5B | -16.3x | --- |
Viking Therapeutics Inc | 6.9B | -67.4x | --- |
Revolution Medicines Inc | 6.3B | -10.1x | --- |
Legend Biotech Corp | 7.5B | -15.9x | --- |
BridgeBio Pharma Inc | 5.2B | -8.7x | --- |
Company Information
Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. It focuses on transform the lives of patients through the development of new therapies for neuroscience diseases, including schizophrenia, Alzheimer’s disease psychosis, epilepsy, panic disorder and Parkinson’s disease. Its pipeline candidates include Emraclidine, Darigabat, Tavapadon and CVL-871. Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype (M4). Darigabat is a PAM that selectively targets the alpha 2/3/5 subunits of the GABAA receptor. Tavapadon is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of Parkinson’s disease.
Contact Information
- Headquarters
- 222 Jacobs Street, Suite 200CAMBRIDGE, MA, United States 02141
- Phone
- 212-284-2300
- Fax
- 302-636-5454
Executives
- Chairperson of the Board of Directors
- N. Coles
- President, Chief Executive Officer, Member of the Board
- Ronald Renaud
- Chief Financial Officer
- Susan Altschuller
- Chief Human Resources Officer
- Kenneth Dipietro
- Senior Vice President - Finance, Chief Accounting Officer
- Mark Bodenrader
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.5B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 182.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.43 |
EPS | $-2.72 |
Book Value | $3.71 |
P/E Ratio | -15.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
